NCT00084981View on ClinicalTrials.gov

Decitabine and Valproic Acid in Treating Patients With Non-Small Cell Lung Cancer

PHASE1CompletedINTERVENTIONAL
Enrollment

25

Participants

Timeline

Start Date

April 30, 2004

Primary Completion Date

February 28, 2013

Conditions
Recurrent Non-small Cell Lung CancerStage IV Non-small Cell Lung Cancer
Interventions
DRUG

decitabine

Given IV

DRUG

valproic acid

Given PO

OTHER

pharmacological study

Correlative studies

OTHER

laboratory biomarker analysis

Correlative studies

Trial Locations (1)

43210

Ohio State University Medical Center, Columbus

All Listed Sponsors
lead

National Cancer Institute (NCI)

NIH

NCT00084981 - Decitabine and Valproic Acid in Treating Patients With Non-Small Cell Lung Cancer | Biotech Hunter | Biotech Hunter